Login to Your Account



Financings Roundup


Thursday, October 13, 2011
United Therapeutics Corp., of Silver Spring, Md., priced its $210 million aggregate principal amount of 1 percent convertible senior notes due 2016 and said its initial purchaser exercised in full its option to purchase up to an additional $40 million in aggregate principal amount to cover overallotments, resulting in a total offering size of $250 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription